DK516288D0 - Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater - Google Patents

Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater

Info

Publication number
DK516288D0
DK516288D0 DK516288A DK516288A DK516288D0 DK 516288 D0 DK516288 D0 DK 516288D0 DK 516288 A DK516288 A DK 516288A DK 516288 A DK516288 A DK 516288A DK 516288 D0 DK516288 D0 DK 516288D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
stabilization
active proteins
therapeutic active
proteins
Prior art date
Application number
DK516288A
Other languages
English (en)
Other versions
DK516288A (da
Inventor
Traute Mundorf
Kurt Schnecker
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of DK516288D0 publication Critical patent/DK516288D0/da
Publication of DK516288A publication Critical patent/DK516288A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK516288A 1987-09-17 1988-09-16 Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater DK516288A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873731255 DE3731255A1 (de) 1987-09-17 1987-09-17 Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen

Publications (2)

Publication Number Publication Date
DK516288D0 true DK516288D0 (da) 1988-09-16
DK516288A DK516288A (da) 1989-03-18

Family

ID=6336244

Family Applications (1)

Application Number Title Priority Date Filing Date
DK516288A DK516288A (da) 1987-09-17 1988-09-16 Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater

Country Status (20)

Country Link
EP (1) EP0307857B1 (da)
JP (1) JP2783552B2 (da)
KR (1) KR970008112B1 (da)
AT (1) ATE126063T1 (da)
AU (1) AU615473B2 (da)
CA (1) CA1329121C (da)
DD (1) DD274562A5 (da)
DE (2) DE3731255A1 (da)
DK (1) DK516288A (da)
ES (1) ES2077559T3 (da)
FI (1) FI95770C (da)
GR (1) GR3017432T3 (da)
HU (1) HU203045B (da)
IE (1) IE70908B1 (da)
IL (1) IL87778A (da)
NO (1) NO179436C (da)
NZ (1) NZ226209A (da)
PT (1) PT88539B (da)
RU (1) RU2093145C1 (da)
ZA (1) ZA886903B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
JPH0776527A (ja) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc 半固形製剤とその製造方法
RU2132184C1 (ru) * 1998-12-16 1999-06-27 Краснодарская научно-исследовательская ветеринарная станция Способ получения препарата "жироформ-плюс" для лечения и профилактики эндометритов у коров
HU230383B1 (hu) * 2000-07-14 2016-03-29 Allergan, Inc Oldékonyságfokozó komponens használata brimodinin-tartarátot tartalmazó vizes készítményekben
RU2216313C2 (ru) * 2000-12-25 2003-11-20 Савченков Сергей Николаевич Лечебно-профилактическое косметическое средство
RU2188665C1 (ru) * 2001-04-09 2002-09-10 Щербакова Элеонора Григорьевна Противовирусное и антибактериальное средство "интерлизин"
ITMI20031640A1 (it) * 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
CU23432B6 (es) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras
BR112012028194A2 (pt) * 2010-05-04 2017-08-08 Viscogel Ab composição, e, processo para preparação da composição
RU2431489C1 (ru) * 2010-05-25 2011-10-20 Федеральное государственное учреждение "Российский научный центр рентгенорадиологии Федерального агентства по высокотехнологичной медицинской помощи" (ФГУ "РНЦРР Росмедтехнологий") Способ лечения хронических воспалительных заболеваний толстого кишечника
AU2018282905B2 (en) 2017-06-12 2022-06-02 Lakewood Amedex, Inc Bisphosphocin gel formulations and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5413223A (en) * 1977-07-01 1979-01-31 Ricoh Co Ltd Printer unit
GB2016015B (en) * 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
FR2513124B1 (fr) * 1981-07-21 1989-11-17 Hayashibara Biochem Lab Production et applications du facteur de lyse des cellules-cibles
CA1190148A (en) * 1981-10-13 1985-07-09 Samuel S. Asculai Interferon-containing compositions
JPS5892622A (ja) * 1981-11-28 1983-06-02 Sunstar Inc インタ−フエロン安定配合製剤
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
JPS5910524A (ja) * 1982-07-08 1984-01-20 Toray Ind Inc インタ−フエロン組成物およびその製造法
JPS6061535A (ja) * 1983-08-24 1985-04-09 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト 製薬学的組成物
EP0177342A3 (en) * 1984-10-04 1987-12-02 Genentech, Inc. Oral formulation of therapeutic proteins
DE3603444A1 (de) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like

Also Published As

Publication number Publication date
PT88539B (pt) 1992-11-30
IE882812L (en) 1989-03-17
DE3731255A1 (de) 1989-04-06
FI884240A0 (fi) 1988-09-15
HUT47436A (en) 1989-03-28
JP2783552B2 (ja) 1998-08-06
JPH01102029A (ja) 1989-04-19
CA1329121C (en) 1994-05-03
AU615473B2 (en) 1991-10-03
ZA886903B (en) 1990-05-30
FI95770B (fi) 1995-12-15
HU203045B (en) 1991-05-28
NO884123D0 (no) 1988-09-16
ES2077559T3 (es) 1995-12-01
KR970008112B1 (ko) 1997-05-21
IL87778A0 (en) 1989-03-31
DK516288A (da) 1989-03-18
FI95770C (fi) 1996-03-25
EP0307857A1 (de) 1989-03-22
KR890004719A (ko) 1989-05-09
IL87778A (en) 1993-05-13
GR3017432T3 (en) 1995-12-31
NO884123L (no) 1989-03-20
AU2231688A (en) 1989-03-23
EP0307857B1 (de) 1995-08-09
ATE126063T1 (de) 1995-08-15
IE70908B1 (en) 1997-01-15
NZ226209A (en) 1991-06-25
NO179436C (no) 1996-10-09
PT88539A (pt) 1988-10-01
RU2093145C1 (ru) 1997-10-20
NO179436B (no) 1996-07-01
DE3854290D1 (de) 1995-09-14
FI884240L (fi) 1989-03-18
DD274562A5 (de) 1989-12-27

Similar Documents

Publication Publication Date Title
DK653688D0 (da) Stabiliserede laegemiddelaktive forbindelser, fremgangsmaade til deres frmstilling samt stabile laegemiddelpraeparater
DK516288A (da) Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater
FI875533L (fi) Insulinpreparat foer non-parenteral dosering.
DK203787D0 (da) Praeparat til nasal administrering
DE58905028D1 (de) Pharmazeutische kombinationspraeparate und deren verwendung als antineoplastische arzneimittel.
ZA885192B (en) Pharmaceutical preparations
PT97160A (pt) Processo para a preparacao de composicoes estaveis para administracao parenterica contendo uma proteina, peptideo ou polipeptideo biologicamente activo
FI862011A0 (fi) Terapeutiska nukleosider.
NO882732D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO884154L (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
ATE33503T1 (de) Pharmazeutische und tiermedizinische praeparate von interleukin-2, in dem cystein-125 ausgetauscht worden ist (muteine), sowie deren herstellung.
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
DE3770280D1 (de) Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha.
ATE56138T1 (de) Perfluorkohlenwasserstoffe als vehikel zur verabreichung von arzneimitteln.
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
DK0458588T3 (da) Behandling af okulær hypertension med en synergistisk kombination til okulær administration
IT1240683B (it) Composizione farmaceutica contenente egf
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
NO913644D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
DE3869156D1 (de) Fungizide 2-anilinthiazoline.
ES2126580T3 (es) Proteina condromodulina-ii.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment